Whitehawk Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
WHWK on Nasdaq
Industry
Pharmaceutical Preparations
Location
2 Headquarters Plaza, East Building, 11 Th Floor, Morristown, NJ

Insiders trading volume in the past year

Whitehawk Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Behzad Aghazadeh Director, Other*, 10%+ Owner $20M Feb 28, 2025
Anupam Dalal Director $8.19M Mar 4, 2025
Caley Castelein Director $5.25M Mar 4, 2025
Baiteng Zhao Director $3M Mar 4, 2025
Neil Desai EXECUTIVE CHAIRMAN, Director $2M -$332K -14.2% Sep 3, 2024
David James Lennon CHIEF EXECUTIVE OFFICER, Director $1.94M -$32.2K -1.63% Apr 1, 2025
Bryan Ball Chief Technical Operations Officer and SVP, Manufacturing Operations $1.37M -$5.05K -0.37% Apr 1, 2025
Scott M. Giacobello Chief Financial Officer $1.19M -$6.59K -0.55% Apr 1, 2025
Lorettta M. Itri Chief Medical Officer $52.3K Mar 1, 2024
Steven Prelack Director $50.5K Jun 30, 2021
Brendan Delaney President and Chief Executive Officer, Director $41.2K Mar 1, 2023
Cheryl Cohen Director $33.3K Jun 30, 2021
Pravin Dugel Director $25.9K Jun 30, 2021
David Dornan Chief Scientific Officer Mar 4, 2025
Karin M. Hehenberger Director Jun 12, 2024
Mohammad Hirmand Director Jun 12, 2024
Emma Reeve Director Jun 12, 2024
Lance E. Thibault Chief Financial Officer Aug 26, 2021
Richard E. Maroun Director Jun 12, 2024

Recent Insider Transactions by Companies or Individuals for Whitehawk Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.